Epidarex-Backed Enterprise Therapeutics Raises £29 million ($41 million USD) Funding
April 12, 2018
Initially founded with capital from leading healthcare investor Epidarex Capital, Enterprise raises Series B round co-led by Versant Ventures and Novartis Venture Fund, with Forbion,